Alpha 2.0
Login Register
» Authors » Yuko Takao

Yuko Takao

Explore the profile of Yuko Takao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 27
Followers 0
Related Specialties
Oncology
Chemistry
Biotechnology
Top 10 Co-Authors
Uhi Toh
Shuko Saku
Yoshito Akagi
Rie Sugihara
Toshinobu Ohno
Sayaka Sakurai
Kazuyuki Moriwaki
Fukashi Matsumoto
Takumi Mizuno
Mina Okabe
Published In
Gan To Kagaku Ryoho
Beilstein J Org Chem
ACS Appl Mater Interfaces
Anticancer Res
World J Surg Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective study
Sugihara R, Watanabe H, Matsushima S, Katagiri Y, Saku S, Okabe M, et al.
World J Surg Oncol . 2024 Nov; 22(1):300. PMID: 39543698
Background: The primary tumor resection (PTR) of de novo stage IV breast cancer (DnIV BC) is controversial, and previous studies have suggested that the neutrophil-to-lymphocyte ratio (NLR) could be a...
2.
Granulomatous mastitis during pregnancy with sudden onset of gait difficulty and erythema nodosum: A case report and review of the literature
Miyahara H, Kurokawa Y, Muto M, Takao Y, Iwanaga E, Mihara Y, et al.
J Obstet Gynaecol Res . 2024 Aug; 50(10):1985-1989. PMID: 39187910
Granulomatous mastitis (GM), a benign inflammatory disease of the breast, often mimics breast cancer on presentation. We present a case of GM during pregnancy manifesting as a breast mass, sudden...
3.
Preferred catalysis distinctly determined by metals doped with nitrogen in three-dimensionally ordered porous carbon materials
Maruyama J, Sato H, Takao Y, Maruyama S, Kato S, Kamiya K, et al.
Nanoscale . 2023 May; 15(23):9954-9963. PMID: 37203995
Three-dimensionally ordered nanoporous structures were generated in carbon materials doped with metals and nitrogen as catalytically active sites for electrochemical reactions. Free-base and metal phthalocyanines with a strategically designed molecular...
4.
Efficacy and Safety of Monthly Minodronate Therapy in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
Ogata N, Toh U, Sudou T, Ogata S, Takao Y, Sugihara R, et al.
Anticancer Res . 2022 Jul; 42(8):4139-4143. PMID: 35896231
Background/aim: Post-menopausal breast cancer (BC) patients who receive adjuvant aromatase inhibitor (AI) therapy may be at increased risk of bone loss, osteoporosis, and bone fracture. We aimed to evaluate the...
5.
Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines
Saku S, Toh U, Takao Y, Sakurai S, Yamada A, Shichijo S, et al.
Exp Ther Med . 2021 Jul; 22(2):905. PMID: 34249152
The present study assessed plasma IgG in patients with metastatic recurrent breast cancer (mrBC) that is reactive to various T-cell epitope peptides of prostate-related antigens (PRAs), such as prostate-specific antigen,...
6.
[Triple-Tracer Technique of Sentinel Lymph Node Biopsy Using Blue Dye plus Radioisotope Combined with Real-Time Indocyanine Green(ICG)Fluorescence Imaging Procedures for Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy]
Takao Y, Toh U, Sakurai S, Saku S, Takenaka M, Akashi M, et al.
Gan To Kagaku Ryoho . 2020 Aug; 47(8):1225-1227. PMID: 32829360
Clinical evidence has indicated that, after neo-adjuvant chemotherapy(NAC), sentinel node(SN)identification rates(IR) were lower and false-negative rates(FNR)were higher for patients(pts)with local advanced breast cancer(BC)than for pts with early stage BC who...
7.
Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer
Toh U, Sakurai S, Saku S, Takao Y, Okabe M, Iwakuma N, et al.
Cancer Sci . 2020 Jun; 111(8):2760-2769. PMID: 32495455
We undertook an early phase II study of mixed 19-peptide cancer vaccine monotherapy for 14 advanced metastatic triple-negative breast cancer (mTNBC) patients refractory to systemic chemotherapy to develop a new...
8.
Controlling the Polarity of Fullerene Derivatives to Optimize Nanomorphology in Blend Films
Matsumoto F, Iwai T, Moriwaki K, Takao Y, Ito T, Mizuno T, et al.
ACS Appl Mater Interfaces . 2016 Feb; 8(7):4803-10. PMID: 26862987
Developing a design strategy to establish the compatibility of acceptor materials with donor materials is important for the rational development of organic solar cells. We synthesized 2,6-dimethoxyphenyl methanofullerene derivatives to...
9.
Design of fullerene derivatives for stabilizing LUMO energy using donor groups placed in spatial proximity to the C60 cage
Matsumoto F, Iwai T, Moriwaki K, Takao Y, Ito T, Mizuno T, et al.
J Org Chem . 2012 Oct; 77(20):9038-43. PMID: 23034001
A series of arylated dihydrofullerene derivatives were synthesized to elucidate the effective design of fullerene derivatives for enhancing the performance of organic photovoltaics. The LUMO energy of the fullerenes was...
10.
[A case of large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix successfully treated by postoperative CPT-11+CDDP chemotherapy after non-curative surgery]
Tanimoto H, Hamasaki A, Akimoto Y, Honda H, Takao Y, Okamoto K, et al.
Gan To Kagaku Ryoho . 2012 Sep; 39(9):1439-41. PMID: 22996787
A 31-year-old woman, gravida 3 para 3, visited a local clinic because of post-coital bleeding. She was diagnosed as having a uterine-cervical tumor and was referred to our hospital. Large...